P.272 Four-drug immunosuppressive treatment as rescue therapy in kidney transplant recipients with repeated episodes of acute rejection or chronic active allograft rejection
Dr. Wanda Rojas, Argentina
P.530 Disseminated cryptococcosis and histoplasmosis in a renal transplant recipient
Dr. Abhishek Suhas Borle, India
P.531 Serum and urine nucleic acid screening tests for BK polyomavirus-associated nephropathy in kidney and kidney-pancreas transplant recipients: Diagnostic test accuracy review
Please note there have been some changes since the abstract submission - Thank you
Dr. Thida Maung Myint, Australia
P.532 Advanced Kaposi Sarcoma With Extensive Pulmonary Involvement After Kidney
Transplantation
Dr. Walaa Dabbas, United States
P.533 A prospective randomised study from Eastern India comparing Basiliximab versus no induction immunosuppression in low immunological risk kidney transplant recipients
Dr. Varun Gosain, India
P.535 One year outcome of Anti-T-Lymphocyte Globulin (ATLG) Induction Therapy in Kidney Transplantation: A Single-Center Retrospective Analysis
Dr. Kamal Kiran Mukkavilli, India
P.534 Comparison of anti-human T-Lymphocyte immunoglobulin (r-ATLG - Grafalon) vs anti-thymocyte globulin (r-ATG - Thymoglobulin) in kidney transplant: A 5-year follow-up study
Dr. Vijay Kumar Sinha, India
P.536 The efficacy of Anti T-Lymphocyte Globulin as Induction Therapy in Kidney Transplantation: A Single-Center Retrospective Analysis
Dr. Piyali Sarkar, India
P.537 Atypical Hemolytic Uremic Syndrome: A Case Report Of 41 Year Old Female
Dr. Piyali Sarkar, India
P.540 Immunosuppressant-induced changes in gut microbiota cause loss of skeletal muscle mass
Dr. Mitsuru Tomizawa, Japan
P.542 Long-term clinical outcomes of late conversion to once-daily tacrolimus and sirolimus combination in stable kidney transplant recipients
Prof. Cheol Woong Jung, Korea
P.547 Tolerogenic properties of CD3 immunotoxin induction therapy and progress toward clinical trials in transplantation